Skip to main navigation menu Skip to main content Skip to site footer

Microbiology

Vol 9 No 2 (2024): December

Development of Tetracycline by AgO Nanoparticles and Studying its Activity on Antibiotic-Resistant Bacteria
Pengembangan Tetrasiklin dengan Nanopartikel AgO dan Mempelajari Aktivitasnya pada Bakteri yang Resisten terhadap Antibiotik



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.10275
Published
October 2, 2024

Abstract

General background: Antibiotic resistance in bacteria has become a critical global health issue, necessitating the development of new strategies to enhance antibiotic efficacy. Specific background: Nanoparticles, particularly silver nanoparticles (AgNPs), have emerged as potential enhancers of antibiotics due to their unique properties and interactions with bacterial cells. Knowledge gap: However, the combination of nanoparticles with existing antibiotics, such as tetracycline, and their impact on bacterial inhibition and safety has not been fully explored. Aims: This study aims to investigate the antibacterial activity of silver oxide nanoparticles (AgO NPs) combined with tetracycline (TCS) and evaluate their effectiveness against resistant bacterial strains. Results: AgO NPs were synthesized using a photodeposition method, yielding nanoparticles with an average diameter of 2.24 nm. The AgO NPs + TCS combination demonstrated superior antibacterial activity, with a minimum inhibitory concentration (MIC) of 16 μg/mL against Staphylococci and 32 μg/mL against Pseudomonas aeruginosa, significantly outperforming standard tetracycline. Hemolysis assays confirmed the safety of the synthesized compound at all concentrations. Novelty: Silver oxide nanoparticles and tetracycline exhibit a unique synergistic interaction, enhancing antimicrobial effects by increasing bacterial membrane permeability, facilitating greater antibiotic infiltration. Implications: These findings suggest that AgO NPs combined with tetracycline offer a promising solution to overcome bacterial resistance, providing a potent and safe alternative to conventional antibiotic treatments.

Highlights:

 

  1. AgO NPs and tetracycline show enhanced antibacterial effects.
  2. More effective than standard tetracycline against resistant bacteria.
  3. Safe with no toxicity observed in hemolysis tests.

 

Keywords: Antibiotic resistance, silver nanoparticles, tetracycline, photodeposition, antibacterial activity

References

  1. . R. D. C. Soltani, M. Mashayekhi, S. Jorfi, A. Khataee, M.-J. Ghanadzadeh, and M. Sillanpää, "Implementation of martite nanoparticles prepared through planetary ball milling as a heterogeneous activator of oxone for degradation of tetracycline antibiotic: ultrasound and peroxy-enhancement," Chemosphere, vol. 210, pp. 699–708, 2018.
  2. . M. Ahmadi, H. Ramezani Motlagh, N. Jaafarzadeh, A. Mostoufi, R. Saeedi, G. Barzegar, and S. Jorfi, "Enhanced photocatalytic degradation of tetracycline and real pharmaceutical wastewater using MWCNT/TiO2 nano-composite," Journal of Environmental Management, vol. 186, pp. 55–63, 2017.
  3. . Y. Yang, X. Zhang, Q. Chen, S. Li, H. Chai, and Y. Huang, "Ultrasound-assisted removal of tetracycline by a Fe/N–C hybrids/H2O2 Fenton-like system," ACS Omega, vol. 3, pp. 15870–15878, 2018.
  4. . S. Aydin, B. Ince, Z. Cetecioglu, O. Arikan, E. G. Ozbayram, A. Shahi, and O. Ince, "Combined effect of erythromycin, tetracycline and sulfamethoxazole on performance of anaerobic sequencing batch reactors," Bioresource Technology, vol. 186, pp. 207–214, 2015.
  5. . S. M. H. Akhter, F. Mohammad, and S. Ahmad, "Plant mediated green synthesis of metal nanoparticles for applications in medicine," Journal of Nanotechnology in Diagnosis and Treatment, vol. 4, pp. 15–24, 2016.
  6. . S. Hiremath, C. Vidya, M. A. L. Antonyraj, M. N. Chandraprabha, and P. Gandhi, "Biosynthesis of Zn nanoparticles assisted by Euphorbia tirucalli (pencil cactus)," International Journal of Current Engineering and Technology, vol. 1, pp. 176–179, 2013.
  7. . Y. Abboud, T. Saffaj, A. Chagraoui, A. El Bouari, K. Brouzi, O. Tanane, and B. Ihssane, "Biosynthesis, characterization and antimicrobial activity of copper oxide nanoparticles (CONPs) produced using brown alga extract (Bifurcaria bifurcata)," Applied Nanoscience, vol. 4, pp. 571–576, 2014.
  8. . P. M. Prashant, N. K. Rana, and S. K. Yadav, "Biosynthesis of nanoparticles: technological concepts and future applications," Journal of Nanoparticle Research, vol. 10, pp. 507–517, 2008.
  9. . H. A. Salam, R. Sivaraj, and R. Venckatesh, "Green synthesis and characterization of zinc oxide nanoparticles from Ocimum basilicum L. var. purpurascens Benth.-Lamiaceae leaf extract," Materials Letters, vol. 131, pp. 16–18, 2014.
  10. . X. Wang, J. Lu, M. Xu, and B. Xing, "Sorption of pyrene by regular and nanoscaled metal oxide particles: influence of adsorbed organic matter," Environmental Science & Technology, vol. 42, pp. 7267–7272, 2008.
  11. . M. Smekalova, V. Aragon, A. Panacek, R. Prucek, R. Zboril, and L. Kvitek, "Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens," Veterinary Journal, vol. 209, pp. 174-179, 2016.
  12. . N. Hari, T. K. Thomas, and A. J. Nair, "Comparative study on the synergistic action of garlic synthesized and citrate capped silver nanoparticles with β-Penem antibiotics," ISRN Nanotechnology, vol. 2013, pp. 1–6, 2013.
  13. . J. Sarkar, D. Chattopadhyay, S. Patra, S. S. Deo, S. Sinha, M. Ghosh, A. Mukherjee, and K. Acharya, "Alternaria alternata mediated synthesis of protein capped silver nanoparticles and their genotoxic activity," Digest Journal of Nanomaterials and Biostructures, vol. 6, no. 2, pp. 563–573, 2011.
  14. . L. Y. Wei, J. R. Lu, H. Z. Xu, A. Patel, Z. S. Chen, and G. F. Chen, "Silver nanoparticles: synthesis, properties, and therapeutic applications," Drug Discovery Today, vol. 20, no. 5, pp. 595–601, 2015.
  15. . R. Thomas, A. P. Nair, K. R. Soumya, J. Mathew, and E. K. Radhakrishnan, "Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative staphylococci isolated from clinical samples," Applied Biochemistry and Biotechnology, vol. 173, no. 2, pp. 449–460, 2014.
  16. . N. Duran, P. D. Marcato, R. De Conti, O. L. Alves, F. T. M. Costa, and M. Brocchi, "Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action," Journal of the Brazilian Chemical Society, vol. 21, no. 6, pp. 949–959, 2010.
  17. . P. Li, J. Li, C. Z. Wu, Q. S. Wu, and J. Li, "Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles," Nanotechnology, vol. 16, no. 9, pp. 1912–1917, 2005.
  18. . K. I. Batarseh, "Anomaly and correlation of killing in the therapeutic properties of silver (1) chelation with glutamic and tartaric acids," Journal of Antimicrobial Chemotherapy, vol. 54, no. 2, pp. 546–548, 2004.
  19. . S. Ghosh, S. Patil, M. Ahire, R. Kitture, S. Kale, K. Pardesi, S. S. Cameotra, J. Bellare, D. D. Dhavale, A. Jabgunde, and B. A. Chopade, "Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents," International Journal of Nanomedicine, vol. 7, pp. 483–496, 2012.
  20. . P. A. Wayne, "Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing," Science China Life Sciences, vol. 54, no. 9, pp. 863–869, 2011.
  21. . J. Tang, M. Kang, H. Chen, X. Shi, R. Zhou, J. Chen, and Y. Du, "The staphylococcal nuclease prevents biofilm formation in Staphylococcus aureus and other biofilm-forming bacteria," Science China Life Sciences, vol. 54, no. 9, pp. 863–869, 2011

Downloads

Download data is not yet available.